RLMD Relmada Therapeutics, Inc.

$6.70 +1.82%

Healthcare · Pharmaceutical Preparations

Relmada Therapeutics, Inc. (RLMD) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $703 million. Shares last traded at $6.70, 20.2% below their 52-week high. Over the past year the stock is up 840.2%. Net profit margin is 0.0%, above the peer median of -0.1%. Revenue grew 4.6% year over year.

Market Cap

$703M

Shares Out

104.9M

EPS (TTM)

$-2.82

P/E Ratio

—

P/S Ratio

45043.23

P/B Ratio

3.21

Dividend / Share

—

Dividend Yield

—

52-Week High

$8.40

52-Week Low

$0.51

Volume

111,020

Avg Vol (3m)

77,189.619

Performance

+2.92%

-4.69%

+7.54%

+49.22%

YTD

+53.49%

+840.22%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

50.32

SMA (50)

$7.02

SMA (200)

$4.61

Price vs SMA50

-4.61%

Price vs SMA200

+45.49%

ATR (14)

$0.48

Financials

Revenue

$0M

Net Income

$0M

Gross Margin

21.8%

Operating Margin

-378798.9%

Net Margin

0.0%

Return on Equity

0.0%

Return on Assets

0.0%

Current Ratio

18.26

Debt / Equity

0.08

Revenue Growth (YoY)

+4.6%

Latest reported annual period ending 2014-02-28 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.22	2026-05-12
FY 2025	$-1.45	2026-03-19
Q3 2025	$-1.16	2025-11-13
Q2 2025	$-0.86	2025-08-07
Q1 2026	$-0.58	2026-05-12
FY 2025	$-2.65	2026-03-19

Full earnings history →

Pharmaceutical Preparations peers

RLMD vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

45043.23 / 3.54 med

+1273155% premium

Net margin vs peers

0.0% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.